AGM Details

The 32nd Annual General Meeting of the members of Novelix Pharmaceuticals Limited (Formerly known as Trimurthi Limited) is scheduled to be held on Wednesday, September 30, 2026, at 03:00 P.M. through Video Conferencing/Other Audio-Visual Means (OAVM).

The Register of Members and the Share Transfer books of the Company will remain closed from Thursday, September 24, 2026, to Wednesday, September 30, 2026 (both days inclusive).

The cut-off date for determining voting rights is Wednesday, September 23, 2026. Voting rights shall be in proportion to shareholders' share in the paid-up equity share capital of the Company as on this date.

Ordinary Business

1. To receive, consider and adopt: The standalone financial statements of the Company which includes the Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss for the financial year ended as on that date and the Cash Flow Statement together with reports of the Board of Directors and the Statutory Auditors thereon.

2. To appoint a director in place of Ms. Sridevi Belide (DIN: 10455373), Non-Executive Director, who retires by rotation, and being eligible, has offered herself for re-appointment.

Special Business

3. Appointment of Mr. Gnana Prakash Gattu as Whole Time Director

To consider and pass a special resolution for the appointment of Mr. Gnana Prakash Gattu (DIN: 00517921) as Whole Time Director of the Company.

Key Terms of Appointment:

  • Designation: Whole-time Director
  • Term: Five consecutive years from August 29, 2026, to August 28, 2031
  • Remuneration: To be determined by the Board from time to time within overall limits prescribed under Companies Act, 2013, and SEBI Listing Regulations
  • Office liable to retirement by rotation in accordance with Section 152 of the Companies Act, 2013

Background: The Board of Directors, at its meeting held on August 29, 2026, based on the recommendation of the Nomination and Remuneration Committee, approved this appointment. Mr. Gattu is currently serving as a Non-Executive Non-Independent Director and possesses considerable experience and knowledge of the business, operations, management and affairs of the Company.

Director Information

Mr. Gnana Prakash Gattu (DIN: 00517921)

  • Currently: Non-Executive Non-Independent Director
  • Proposed: Whole-time Director
  • Shares held: 4,00,000 shares in the Company
  • Board meetings attended during FY 2025-2026: 8 meetings
  • No directorships in other listed entities
  • Not debarred or disqualified from being appointed as a Director

Ms. Sridevi Belide (DIN: 10455373)

  • Position: Non-Executive Director (retiring by rotation)
  • Date of Birth: 20/07/2000 (Age: 25 years)
  • Date of First Appointment: 23/10/2025
  • Qualifications: MBBS
  • Brief resume: Medical professional holding MBBS degree, bringing expertise in healthcare and scientific understanding to corporate leadership
  • Relationship: Related to the Promoters/Promoter Group of the Company
  • Shares held: Nil
  • Board meetings attended during FY 2025-2026: 6 meetings
  • No directorships in other listed entities

Voting Arrangements

Central Depository Services Limited (CDSL) will provide facility for voting through remote e-Voting for the 32nd AGM and e-Voting during the AGM.

Remote e-Voting Period: Begins on September 27, 2026, at 09:00 A.M. and ends on September 29, 2026, at 05:00 P.M.

Voting Methods:

  • Individual shareholders holding shares in demat mode: Access through CDSL/NSDL e-Voting system using demat account credentials
  • Shareholders holding shares in physical mode and non-individual shareholders in demat mode: Access through CDSL e-Voting system at www.evotingindia.com

Meeting Attendance: Members can join the AGM through VC/OAVM 15 minutes before and after the scheduled commencement time. The facility will be available to at least 1000 members on first-come-first-served basis, excluding large shareholders (holding 2% or more), promoters, institutional investors, directors, KMPs, committee chairpersons, and auditors who can attend without restriction.

Additional Information

The notice has been uploaded on the company's website (www.novelixpharma.com) and the websites of BSE Limited (www.bseindia.com) and CDSL (www.evotingindia.com).

Members holding shares in physical form are requested to provide necessary details like Folio No., Name, scanned copy of share certificate, PAN, and AADHAR by email to the Company at novelixpharmaceuticals@gmail.com or RTA at info@vccilindia.com.

The company has sent individual letters to all members holding shares in physical form for furnishing their PAN, KYC details and Nomination pursuant to SEBI Circular dated November 3, 2021.